
The Evolving Role of AI in Modernizing Clinical Trials - with Xiong Liu of Novartis
The AI in Business Podcast
00:00
Transforming Clinical Trials with AI and Decentralization
This chapter explores the impact of federated learning and decentralized clinical trials on the healthcare landscape, highlighting the adoption of DCT methods by pharmaceutical companies. It discusses the advantages of these new approaches, including improved efficiency and patient engagement, alongside the ethical considerations of using AI in research. The conversation emphasizes the importance of patient trust and the collaboration required to navigate the integration of technology in clinical trials.
Transcript
Play full episode